DaVita (DVA) Q1 2026 Earnings Report Exceeds Expectations
DaVita (DVA) reported Q1 2026 earnings that exceeded expectations, with adjusted operating income of $482 million, beating forecasts by $50 million. The company also reported adjusted EPS of $2.87 and maintained its full-year free cash flow guidance at $140 million. U.S. dialysis treatment volume declined slightly, but management raised its annual growth forecast.
Tickers: $DVA
Topics: adjusted_eps dialysis earnings free_cash_flow operating_income revenue_per_treatment